H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 8.6% of adults in Boston have diagnosed diabetes — 3.4 points below the U.S. 12% figure. Census population 675,647. Massachusetts Medicare wound biologics: National Government Services (NGS) (JK). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Boston clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Boston storefront.
Pressure Ulcer Treatment Solutions in Boston, MA for clinics & physicians. Advanced pressure ulcer treatme… Compliance support & pricing — contact Hawk Medical.
Joe Bradley will tell you the same thing he tells his own staff: epidemiology first, then MAC, then SKU. CDC PLACES (2023, crude) estimates 8.6% of adults in Boston have diagnosed diabetes — 3.4 points below the U.S. 12% figure. 6.3% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. Then we pick pressure ulcer treatment against that mix.
National Pressure Ulcer Treatment Solutions notes (how the product actually works)JK reviewers still want serial wound measurements and conservative-care history before CTPs, whether diabetes in Boston is 8.6% or not. PLACES is planning data. The LCD is the claim.
We are not going to invent a Boston warehouse or a five-star local review. What you get is pressure ulcer treatment from FDA-registered sources, lot paperwork, and someone who has run the same SOPs in clinic — Joe Bradley. The local numbers on this page are CDC PLACES and CMS JK, not marketing adjectives.
CDC PLACES (2023, crude prevalence) estimates 8.6% of adults — 3.4 points below the U.S. 12% figure. Obesity is 23.4%; arthritis is 17.8%. That is place-level BRFSS modeling, not a clinic census and not a Boston trial.
Point-of-care spin, kit handling, and documentation basics. Injection technique, privileging, and ultrasound guidance remain the clinic’s clinical education path in Massachusetts.
No. Hawk Medical does not distribute products as “stem cell therapy.” HCT/P 361 allografts are regulated under 21 CFR 1271 for homologous use and minimal manipulation. PRP is autologous. Marketing that blurs those lanes is a compliance problem in every state, including Massachusetts.
It is the Census city-proper count — useful as scale for a city of 500k–1M. It is not a count of orthopedic groups, wound centers, or competitors. Underwrite the program against your referral sources, not against the skyline.
If you operate in Massachusetts and another MAC state, say it on the first call. JK will not port 1:1. We would rather split utilization than watch a sister clinic copy Boston tickets into the wrong jurisdiction.
Contact us to learn how Hawk Medical supports practices in Boston, MA.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Boston is JK geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Boston — 3.4 points below the U.S. 12% figure. Planning input, not an outcomes claim.
Massachusetts Part B wound biologics follow this contractor (siblings: CT, ME, NH, NY, RI, VT). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Boston. Useful for joint-program math; still needs a diagnosis and privileging.
No Boston storefront. Joe Bradley is an active practice owner. pressure ulcer treatment stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.